STAT3-IN-12
|
S658739-25mg
|
≥99% |
N/A |
25mg
|
¥ 5500.9
|
期货,请咨询 |
阿拉丁 |
STAT3-IN-12
|
S658739-10mg
|
≥99% |
N/A |
10mg
|
¥ 2500.9
|
期货,请咨询 |
阿拉丁 |
SNIPER(ABL)-020
|
S658736-5mg
|
≥99% |
N/A |
5mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
SNIPER(ABL)-020
|
S658736-50mg
|
≥99% |
N/A |
50mg
|
¥ 38000.9
|
期货,请咨询 |
阿拉丁 |
SNIPER(ABL)-020
|
S658736-10mg
|
≥99% |
N/A |
10mg
|
¥ 14500.9
|
期货,请咨询 |
阿拉丁 |
Sovesudil hydrochloride
|
S658733-5mg
|
≥99% |
N/A |
5mg
|
¥ 5000.9
|
期货,请咨询 |
阿拉丁 |
Sovesudil hydrochloride
|
S658733-10mg
|
≥99% |
N/A |
10mg
|
¥ 8500.9
|
期货,请咨询 |
阿拉丁 |
Super-TDU (1-31) (TFA)
|
S658732-1mg
|
≥99% |
N/A |
1mg
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |
SB1-G-187
|
S658728-5mg
|
≥98% |
2769753-18-4 |
5mg
|
¥ 7800.9
|
期货,请咨询 |
阿拉丁 |
SB1-G-187
|
S658728-10mg
|
≥98% |
2769753-18-4 |
10mg
|
¥ 12500.9
|
期货,请咨询 |
阿拉丁 |
sGnRH-A acetate
|
S658715-5mg
|
≥99% |
N/A |
5mg
|
¥ 4200.9
|
期货,请咨询 |
阿拉丁 |
sGnRH-A acetate
|
S658715-1mg
|
≥99% |
N/A |
1mg
|
¥ 1400.9
|
期货,请咨询 |
阿拉丁 |
sGnRH-A acetate
|
S658715-10mg
|
≥99% |
N/A |
10mg
|
¥ 6700.9
|
期货,请咨询 |
阿拉丁 |
Saralasin TFA
|
S658680-5mg
|
≥98% |
N/A |
5mg
|
¥ 3500.9
|
期货,请咨询 |
阿拉丁 |
Saralasin TFA
|
S658680-10mg
|
≥98% |
N/A |
10mg
|
¥ 5800.9
|
期货,请咨询 |
阿拉丁 |
STING agonist-8 dihydrochloride
|
S658662-5mg
|
|
N/A |
5mg
|
¥ 12800.9
|
期货,请咨询 |
阿拉丁 |
STING agonist-8 dihydrochloride
|
S658662-1mg
|
|
N/A |
1mg
|
¥ 4500.9
|
期货,请咨询 |
阿拉丁 |
SOR-C13 TFA
|
S658642-5mg
|
≥99% |
N/A |
5mg
|
¥ 1800.9
|
期货,请咨询 |
阿拉丁 |
SOR-C13 TFA
|
S658642-1mg
|
≥99% |
N/A |
1mg
|
¥ 700.9
|
期货,请咨询 |
阿拉丁 |
SOR-C13 TFA
|
S658642-10mg
|
≥99% |
N/A |
10mg
|
¥ 2800.9
|
期货,请咨询 |
阿拉丁 |
SHP2-IN-9
|
S658641-5mg
|
≥98% |
N/A |
5mg
|
¥ 1300.9
|
期货,请咨询 |
阿拉丁 |
SHP2-IN-9
|
S658641-50mg
|
≥98% |
N/A |
50mg
|
¥ 7000.9
|
期货,请咨询 |
阿拉丁 |
SHP2-IN-9
|
S658641-25mg
|
≥98% |
N/A |
25mg
|
¥ 4400.9
|
期货,请咨询 |
阿拉丁 |
SHP2-IN-9
|
S658641-10mg
|
≥98% |
N/A |
10mg
|
¥ 2100.9
|
期货,请咨询 |
阿拉丁 |